Patents by Inventor Daiki Matsuda

Daiki Matsuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210290756
    Abstract: Provided herein are nucleic acid molecules encoding viral replication proteins and antigenic coronavirus proteins or fragments thereof. Also provided herein are compositions that include nucleic acid molecules encoding viral replication and antigenic proteins, and lipids. Nucleic acid molecules provided herein are useful for inducing immune responses.
    Type: Application
    Filed: March 9, 2021
    Publication date: September 23, 2021
    Inventors: Sean Michael SULLIVAN, Daiki MATSUDA, Kiyoshi TACHIKAWA, Padmanabh CHIVUKULA, Priya Prakash KARMALI, Jared Henry DAVIS, Yanjie BAO, Amit SAGI
  • Patent number: 11126422
    Abstract: A program update system updating programs comprising: a first control device executing a program stored in the primary storage area thereof; a second control device executing a program stored in the primary storage area thereof; a program storage temporarily storing an acquired program; a program acquirer preferentially acquiring and storing into the program storage a first program to be stored in the first control device, and acquiring and storing into the program storage a second program to be stored in the second control device; and an update unit storing the first program stored in the program storage into the primary storage area of the first control device, storing the second program stored in the program storage into the primary storage area of the second control device, and switching the primary storage area and the secondary storage area of the first control device.
    Type: Grant
    Filed: March 3, 2020
    Date of Patent: September 21, 2021
    Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
    Inventors: Daiki Matsuda, Yasushi Kojima, Takahiko Kamitsuji
  • Publication number: 20200285458
    Abstract: A program update system updating programs comprising: a first control device executing a program stored in the primary storage area thereof; a second control device executing a program stored in the primary storage area thereof; a program storage temporarily storing an acquired program; a program acquirer preferentially acquiring and storing into the program storage a first program to be stored in the first control device, and acquiring and storing into the program storage a second program to be stored in the second control device; and an update unit storing the first program stored in the program storage into the primary storage area of the first control device, storing the second program stored in the program storage into the primary storage area of the second control device, and switching the primary storage area and the secondary storage area of the first control device.
    Type: Application
    Filed: March 3, 2020
    Publication date: September 10, 2020
    Applicant: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
    Inventors: Daiki MATSUDA, Yasushi KOJIMA, Takahiko KAMITSUJI
  • Publication number: 20200181584
    Abstract: The present disclosure provides a modified human OTC protein having improved properties for the treatment of OTC deficiency in a patient. Preferably, the protein of the disclosure is produced from a codon optimized mRNA suitable for administration to a patient suffering from OTC deficiency wherein upon administration of the mRNA to the patient, the protein of the disclosure is expressed in the patient in therapeutically effective amounts to treat OTC deficiency. The present disclosure also provides codon optimized mRNA sequences encoding wild type human OTC comprising a 5? UTR derived from a gene expressed by Arabidopsis thaliana for use in treating OTC deficiency in a patient.
    Type: Application
    Filed: December 5, 2019
    Publication date: June 11, 2020
    Inventors: Carlos G. PEREZ-GARCIA, Kiyoshi TACHIKAWA, Daiki MATSUDA, Padmanabh CHIVUKULA
  • Patent number: 10479201
    Abstract: An in-vehicle display system is provided with first display unit, second display unit, vehicle information acquisition unit, and CPU. When a display operation for outputting at least a portion of first content to second display unit with the first content being output to first display unit is performed, CPU selects either of first display unit and second display unit with which to associate an authority to operate the output of at least one of first display unit and second display unit according to at least one signal from among a plurality of signals indicating a type of the first content, an attribute of first display unit, an attribute of second display unit, vehicle information, and a detail of the display operation.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: November 19, 2019
    Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
    Inventors: Koji Hamasaki, Daiki Matsuda, Koumei Kubota
  • Publication number: 20190070959
    Abstract: An in-vehicle display system is provided with first display unit, second display unit, vehicle information acquisition unit, and CPU. When a display operation for outputting at least a portion of first content to second display unit with the first content being output to first display unit is performed, CPU selects either of first display unit and second display unit with which to associate an authority to operate the output of at least one of first display unit and second display unit according to at least one signal from among a plurality of signals indicating a type of the first content, an attribute of first display unit, an attribute of second display unit, vehicle information, and a detail of the display operation.
    Type: Application
    Filed: October 5, 2016
    Publication date: March 7, 2019
    Inventors: KOJI HAMASAKI, DAIKI MATSUDA, KOUMEI KUBOTA
  • Publication number: 20180327471
    Abstract: A range of therapeutic mRNA molecules expressible to provide a target polypeptide or protein. The RNA molecules can contain one or more 5-methoxyuridines and 5-methylcytidines. Further provided are DNA templates, which can be transcribed to provide a target mRNA, and can have altered nucleotides, such as reduced deoxyadenosines. This invention also provides processes for making the therapeutic mRNA molecules. The RNA molecules can be translated in vitro or in vivo to provide an active polypeptide or protein.
    Type: Application
    Filed: February 27, 2018
    Publication date: November 15, 2018
    Inventors: Pattraranee Limphong, Kiyoshi Tachikawa, Padmanabh Chivukula, Daiki Matsuda, Arisa Cale